F. Van-den-hoogen, Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative: ACR/EULAR Classification Criteria for SSc, Arthritis & Rheumatism, vol.65, pp.2737-2747, 2013.

W. Zhao, The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms, Rheumatol Int, vol.37, pp.1303-1310, 2017.

H. Chu, Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes, Am J Respir Cell Mol Biol, vol.58, pp.28-39, 2018.

E. Kaspi, Identification of CD146 as a novel molecular actor involved in systemic sclerosis, Journal of Allergy and Clinical Immunology, vol.140, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01778289

N. Bardin, V. Francès, V. Combes, J. Sampol, and F. Dignat-george, CD146: biosynthesis and production of a soluble form in human cultured endothelial cells, FEBS Letters, vol.421, pp.12-14, 1998.

N. Bardin, S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen, Tissue Antigens, vol.48, pp.531-539, 1996.

N. Bardin, Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion, Blood, vol.98, pp.3677-3684, 2001.

N. Bardin, CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration, ATVB, vol.29, pp.746-753, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00428932

A. Kebir, CD146 Short Isoform Increases the Proangiogenic Potential of Endothelial Progenitor Cells In Vitro and In Vivo, Circulation Research, vol.107, pp.66-75, 2010.

N. Bardin, Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease, Inflammatory Bowel Diseases, vol.12, pp.16-21, 2006.

T. Ito, Elevated serum levels of soluble CD146 in patients with systemic sclerosis, Clin Rheumatol, vol.36, pp.119-124, 2017.

H. Zheng, G. Chen, L. A. Delouise, and Z. Lou, Detection of the Cancer Marker CD146 Expression in Melanoma Cells with Semiconductor Quantum Dot Label, j biomed nanotechnol, vol.6, pp.303-311, 2010.

E. Kaspi, Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development, Angiogenesis, vol.16, pp.329-342, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02385712

C. Wu, J. C. Goodall, R. Busch, and J. S. Gaston, Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon-? by CD4 + T cells in patients with inflammatory arthritis: Cytokine secretion by CD146 + CD4 + T cells, Clin Exp Immunol, vol.179, pp.378-391, 2015.

G. Castro, ROR?t and ROR? signature genes in human TH17 cells, PLoS One, vol.12, p.181868, 2017.

C. Gu, L. Wu, and X. Li, IL-17 family: Cytokines, receptors and signaling, Cytokine, vol.64, pp.477-485, 2013.

P. B?l?nescu, E. B?l?nescu, and A. B?l?nescu, IL-17 and TH17 cells in systemic sclerosis: a comprehensive review, Romanian Journal of Internal Medicine, vol.55, pp.198-204, 2017.

N. Amatya, A. V. Garg, and S. L. Gaffen, IL-17 Signaling: The Yin and the Yang, Trends in Immunology, vol.38, pp.310-322, 2017.

Y. Zhou, The elevated expression of TH17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis, Human Immunology, vol.76, pp.22-29, 2015.

S. K. Bedoya, B. Lam, K. Lau, and . Larkin, J. TH17 Cells in Immunity and Autoimmunity. Clinical and Developmental Immunology, vol.2013, pp.1-16, 2013.

M. Truchetet, N. C. Brembilla, E. Montanari, Y. Allanore, and C. Chizzolini, Increased frequency of circulating Th22 in addition to TH17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease, Arthritis Res Ther, vol.13, p.166, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00643830

N. Bardin, Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration, Thromb Haemost, vol.90, pp.915-920, 2003.

N. Despoix, Mouse CD146/MCAM is a marker of natural killer cell maturation, Eur. J. Immunol, vol.38, pp.2855-2864, 2008.

P. K. Dagur, MCAM-expressing CD4+ T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases, Journal of Autoimmunity, vol.37, pp.319-327, 2011.